脂肪肝治療の世界市場（～2026年）

• 英文タイトル：Global Fatty Liver Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11923
• 出版社/出版日：QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は脂肪肝治療のグローバル市場について調査・分析したレポートです。種類別（チアゾリジンジオン、ビタミンE、メトホルミンスタチン、多価不飽和脂肪酸、アンジオテンシン受容体遮断薬、ペントキシフィリン）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別脂肪肝治療の競争状況、市場シェア
・世界の脂肪肝治療市場：種類別市場規模 2015年-2020年（チアゾリジンジオン、ビタミンE、メトホルミンスタチン、多価不飽和脂肪酸、アンジオテンシン受容体遮断薬、ペントキシフィリン）
・世界の脂肪肝治療市場：種類別市場規模予測 2021年-2026年（チアゾリジンジオン、ビタミンE、メトホルミンスタチン、多価不飽和脂肪酸、アンジオテンシン受容体遮断薬、ペントキシフィリン）
・世界の脂肪肝治療市場：用途別市場規模 2015年-2020年（病院・クリニック、その他）
・世界の脂肪肝治療市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他）
・北米の脂肪肝治療市場分析：米国、カナダ
・ヨーロッパの脂肪肝治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの脂肪肝治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の脂肪肝治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの脂肪肝治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Cardax、Daewoong、Roche、Glenmark、GW、Limerick BioPharma、Merck、Novartis、Orchid、AstraZeneca
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Fatty liver disease is one of the most common liver dysfunction where the triglyceride fat accumulates in liver cells.
The major risks associated with fatty liver disease are alcoholic cirrhosis, cardiovascular disorder, metabolic syndrome and biliary cirrhosis among others.

Market Analysis and Insights: Global Fatty Liver Treatment Market
The global Fatty Liver Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Fatty Liver Treatment Scope and Market Size
Fatty Liver Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Fatty Liver Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Cardax
Daewoong
Roche
Glenmark
GW
Limerick BioPharma
Merck
Novartis
Orchid
AstraZeneca

Market segment by Type, the product can be split into
Thiazolidinedione
Vitamin E
Metformin Statins
Polyunsaturated Fatty Acids
Angiotensin Receptor Blockers
Pentoxifylline
Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Fatty Liver Treatment Revenue
1.4 Market by Type
1.4.1 Global Fatty Liver Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Thiazolidinedione
1.4.3 Vitamin E
1.4.4 Metformin Statins
1.4.5 Polyunsaturated Fatty Acids
1.4.6 Angiotensin Receptor Blockers
1.4.7 Pentoxifylline
1.5 Market by Application
1.5.1 Global Fatty Liver Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Fatty Liver Treatment Market Perspective (2015-2026)
2.2 Global Fatty Liver Treatment Growth Trends by Regions
2.2.1 Fatty Liver Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Fatty Liver Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Fatty Liver Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Fatty Liver Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Fatty Liver Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Fatty Liver Treatment Players by Market Size
3.1.1 Global Top Fatty Liver Treatment Players by Revenue (2015-2020)
3.1.2 Global Fatty Liver Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Fatty Liver Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Fatty Liver Treatment Market Concentration Ratio
3.2.1 Global Fatty Liver Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Fatty Liver Treatment Revenue in 2019
3.3 Fatty Liver Treatment Key Players Head office and Area Served
3.4 Key Players Fatty Liver Treatment Product Solution and Service
3.5 Date of Enter into Fatty Liver Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Fatty Liver Treatment Historic Market Size by Type (2015-2020)
4.2 Global Fatty Liver Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Fatty Liver Treatment Market Size by Application (2015-2020)
5.2 Global Fatty Liver Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Fatty Liver Treatment Market Size (2015-2020)
6.2 Fatty Liver Treatment Key Players in North America (2019-2020)
6.3 North America Fatty Liver Treatment Market Size by Type (2015-2020)
6.4 North America Fatty Liver Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Fatty Liver Treatment Market Size (2015-2020)
7.2 Fatty Liver Treatment Key Players in Europe (2019-2020)
7.3 Europe Fatty Liver Treatment Market Size by Type (2015-2020)
7.4 Europe Fatty Liver Treatment Market Size by Application (2015-2020)

8 China
8.1 China Fatty Liver Treatment Market Size (2015-2020)
8.2 Fatty Liver Treatment Key Players in China (2019-2020)
8.3 China Fatty Liver Treatment Market Size by Type (2015-2020)
8.4 China Fatty Liver Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Fatty Liver Treatment Market Size (2015-2020)
9.2 Fatty Liver Treatment Key Players in Japan (2019-2020)
9.3 Japan Fatty Liver Treatment Market Size by Type (2015-2020)
9.4 Japan Fatty Liver Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Fatty Liver Treatment Market Size (2015-2020)
10.2 Fatty Liver Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Fatty Liver Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Fatty Liver Treatment Market Size by Application (2015-2020)

11 India
11.1 India Fatty Liver Treatment Market Size (2015-2020)
11.2 Fatty Liver Treatment Key Players in India (2019-2020)
11.3 India Fatty Liver Treatment Market Size by Type (2015-2020)
11.4 India Fatty Liver Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Fatty Liver Treatment Market Size (2015-2020)
12.2 Fatty Liver Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Fatty Liver Treatment Market Size by Type (2015-2020)
12.4 Central & South America Fatty Liver Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Cardax
13.1.1 Cardax Company Details
13.1.2 Cardax Business Overview
13.1.3 Cardax Fatty Liver Treatment Introduction
13.1.4 Cardax Revenue in Fatty Liver Treatment Business (2015-2020))
13.1.5 Cardax Recent Development
13.2 Daewoong
13.2.1 Daewoong Company Details
13.2.2 Daewoong Business Overview
13.2.3 Daewoong Fatty Liver Treatment Introduction
13.2.4 Daewoong Revenue in Fatty Liver Treatment Business (2015-2020)
13.2.5 Daewoong Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche Fatty Liver Treatment Introduction
13.3.4 Roche Revenue in Fatty Liver Treatment Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Glenmark
13.4.1 Glenmark Company Details
13.4.2 Glenmark Business Overview
13.4.3 Glenmark Fatty Liver Treatment Introduction
13.4.4 Glenmark Revenue in Fatty Liver Treatment Business (2015-2020)
13.4.5 Glenmark Recent Development
13.5 GW
13.5.1 GW Company Details
13.5.2 GW Business Overview
13.5.3 GW Fatty Liver Treatment Introduction
13.5.4 GW Revenue in Fatty Liver Treatment Business (2015-2020)
13.5.5 GW Recent Development
13.6 Limerick BioPharma
13.6.1 Limerick BioPharma Company Details
13.6.2 Limerick BioPharma Business Overview
13.6.3 Limerick BioPharma Fatty Liver Treatment Introduction
13.6.4 Limerick BioPharma Revenue in Fatty Liver Treatment Business (2015-2020)
13.6.5 Limerick BioPharma Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Fatty Liver Treatment Introduction
13.7.4 Merck Revenue in Fatty Liver Treatment Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Fatty Liver Treatment Introduction
13.8.4 Novartis Revenue in Fatty Liver Treatment Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Orchid
13.9.1 Orchid Company Details
13.9.2 Orchid Business Overview
13.9.3 Orchid Fatty Liver Treatment Introduction
13.9.4 Orchid Revenue in Fatty Liver Treatment Business (2015-2020)
13.9.5 Orchid Recent Development
13.10 AstraZeneca
13.10.1 AstraZeneca Company Details
13.10.2 AstraZeneca Business Overview
13.10.3 AstraZeneca Fatty Liver Treatment Introduction
13.10.4 AstraZeneca Revenue in Fatty Liver Treatment Business (2015-2020)
13.10.5 AstraZeneca Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Fatty Liver Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Fatty Liver Treatment Revenue
Table 3. Ranking of Global Top Fatty Liver Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Fatty Liver Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Thiazolidinedione
Table 6. Key Players of Vitamin E
Table 7. Key Players of Metformin Statins
Table 8. Key Players of Polyunsaturated Fatty Acids
Table 9. Key Players of Angiotensin Receptor Blockers
Table 10. Key Players of Pentoxifylline
Table 11. Global Fatty Liver Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Fatty Liver Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Fatty Liver Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Fatty Liver Treatment Market Share by Regions (2015-2020)
Table 15. Global Fatty Liver Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Fatty Liver Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Fatty Liver Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Fatty Liver Treatment Players
Table 22. Global Fatty Liver Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Fatty Liver Treatment Market Share by Players (2015-2020)
Table 24. Global Top Fatty Liver Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fatty Liver Treatment as of 2019)
Table 25. Global Fatty Liver Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Fatty Liver Treatment Product Solution and Service
Table 28. Date of Enter into Fatty Liver Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Fatty Liver Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Fatty Liver Treatment Market Size Share by Type (2015-2020)
Table 32. Global Fatty Liver Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Fatty Liver Treatment Market Size Share by Application (2015-2020)
Table 34. Global Fatty Liver Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Fatty Liver Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Fatty Liver Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Fatty Liver Treatment Market Share (2019-2020)
Table 38. North America Fatty Liver Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Fatty Liver Treatment Market Share by Type (2015-2020)
Table 40. North America Fatty Liver Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Fatty Liver Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Fatty Liver Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Fatty Liver Treatment Market Share (2019-2020)
Table 44. Europe Fatty Liver Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Fatty Liver Treatment Market Share by Type (2015-2020)
Table 46. Europe Fatty Liver Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Fatty Liver Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Fatty Liver Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Fatty Liver Treatment Market Share (2019-2020)
Table 50. China Fatty Liver Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Fatty Liver Treatment Market Share by Type (2015-2020)
Table 52. China Fatty Liver Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Fatty Liver Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Fatty Liver Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Fatty Liver Treatment Market Share (2019-2020)
Table 56. Japan Fatty Liver Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Fatty Liver Treatment Market Share by Type (2015-2020)
Table 58. Japan Fatty Liver Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Fatty Liver Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Fatty Liver Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Fatty Liver Treatment Market Share (2019-2020)
Table 62. Southeast Asia Fatty Liver Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Fatty Liver Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Fatty Liver Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Fatty Liver Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Fatty Liver Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Fatty Liver Treatment Market Share (2019-2020)
Table 68. India Fatty Liver Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Fatty Liver Treatment Market Share by Type (2015-2020)
Table 70. India Fatty Liver Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Fatty Liver Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Fatty Liver Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Fatty Liver Treatment Market Share (2019-2020)
Table 74. Central & South America Fatty Liver Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Fatty Liver Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Fatty Liver Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Fatty Liver Treatment Market Share by Application (2015-2020)
Table 78. Cardax Company Details
Table 79. Cardax Business Overview
Table 80. Cardax Product
Table 81. Cardax Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 82. Cardax Recent Development
Table 83. Daewoong Company Details
Table 84. Daewoong Business Overview
Table 85. Daewoong Product
Table 86. Daewoong Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 87. Daewoong Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Product
Table 91. Roche Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 92. Roche Recent Development
Table 93. Glenmark Company Details
Table 94. Glenmark Business Overview
Table 95. Glenmark Product
Table 96. Glenmark Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 97. Glenmark Recent Development
Table 98. GW Company Details
Table 99. GW Business Overview
Table 100. GW Product
Table 101. GW Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 102. GW Recent Development
Table 103. Limerick BioPharma Company Details
Table 104. Limerick BioPharma Business Overview
Table 105. Limerick BioPharma Product
Table 106. Limerick BioPharma Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 107. Limerick BioPharma Recent Development
Table 108. Merck Company Details
Table 109. Merck Business Overview
Table 110. Merck Product
Table 111. Merck Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 112. Merck Recent Development
Table 113. Novartis Business Overview
Table 114. Novartis Product
Table 115. Novartis Company Details
Table 116. Novartis Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 117. Novartis Recent Development
Table 118. Orchid Company Details
Table 119. Orchid Business Overview
Table 120. Orchid Product
Table 121. Orchid Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 122. Orchid Recent Development
Table 123. AstraZeneca Company Details
Table 124. AstraZeneca Business Overview
Table 125. AstraZeneca Product
Table 126. AstraZeneca Revenue in Fatty Liver Treatment Business (2015-2020) (Million US$)
Table 127. AstraZeneca Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fatty Liver Treatment Market Share by Type: 2020 VS 2026
Figure 2. Thiazolidinedione Features
Figure 3. Vitamin E Features
Figure 4. Metformin Statins Features
Figure 5. Polyunsaturated Fatty Acids Features
Figure 6. Angiotensin Receptor Blockers Features
Figure 7. Pentoxifylline Features
Figure 8. Global Fatty Liver Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Fatty Liver Treatment Report Years Considered
Figure 12. Global Fatty Liver Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Fatty Liver Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Fatty Liver Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Fatty Liver Treatment Market Share by Players in 2019
Figure 17. Global Top Fatty Liver Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fatty Liver Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Fatty Liver Treatment Revenue in 2019
Figure 19. North America Fatty Liver Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Fatty Liver Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Fatty Liver Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Fatty Liver Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Fatty Liver Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Fatty Liver Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Fatty Liver Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介

非アルコール性脂肪性肝疾患治療の世界市場（～2026年）

Global Non Alcoholic Fatty Liver Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03992 2020年11月20日 97Pages
当調査資料は非アルコール性脂肪性肝疾患治療のグローバル市場について調査・分析したレポートです。種類別（酸化防止剤、チアゾリジンジオン、ビグアニド、脂質低下剤、FXR受容体作動薬、その他）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、オンライン薬局、その他）市場規模、地域別（北米、米国、カナダ...

非アルコール性脂肪肝疾患治療薬の世界市場（～2026年）

Global Nonalcoholic Fatty Liver Disease Therapeutics Market Size, Status and Forecast 2020-2026
MRC2-11QY03994 2020年11月20日 95Pages
当調査資料は非アルコール性脂肪肝疾患治療薬のグローバル市場について調査・分析したレポートです。種類別（経口、非経口）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

肝疾患治療の世界市場（～2026年）

Global Liver Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12531 2020年11月25日 94Pages
当調査資料は肝疾患治療のグローバル市場について調査・分析したレポートです。種類別（肝臓有毒傷害、感染性病原体・寄生虫、免疫障害、腫瘍、遺伝性肝疾患）市場規模、用途別（病院、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

遊離脂肪酸受容体4の世界市場（～2026年）

Global Free Fatty Acid Receptor 4 Market Insights and Forecast to 2026
MRC2-11QY06507 2020年11月20日 113Pages
当調査資料は遊離脂肪酸受容体4のグローバル市場について調査・分析したレポートです。種類別（CB-001、GSK-137647A、SC-410、その他）市場規模、用途別（非アルコール性脂肪性肝疾患、2型糖尿病、代謝性疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

肝生検の世界市場（～2026年）

Global Liver Biopsy Market Size, Status and Forecast 2020-2026
MRC2-11QY12529 2020年11月25日 96Pages
当調査資料は肝生検のグローバル市場について調査・分析したレポートです。種類別（経皮的、経頸静脈的、腹腔鏡下）市場規模、用途別（病院・クリニック、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

肝硬変の世界市場（～2026年）

Global Liver Cirrhosis Market Size, Status and Forecast 2020-2026
MRC2-11QY12530 2020年11月25日 98Pages
当調査資料は肝硬変のグローバル市場について調査・分析したレポートです。種類別（アルコール性肝硬変、萎縮性肝硬変、胆汁性肝硬変、心臓性肝硬変、クリプトジェニック肝硬変）市場規模、用途別（病院、専門クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア...

ヒト化肝臓マウスモデルの世界市場（～2026年）

Global Humanized Liver Mice Models Market Size, Status and Forecast 2020-2026
MRC2-11QY12259 2020年11月25日 98Pages
当調査資料はヒト化肝臓マウスモデルのグローバル市場について調査・分析したレポートです。種類別（uPA/SCIDマウスモデル、FRGマウスモデル、TK-NOGマウスモデル、その他）市場規模、用途別（バイオエンジニアリング、メディカルエンジニアリング、その他）市場規模、地域別（北米、米国、カナダ、ヨーロ...

サメ肝油の世界市場（～2026年）

Global Shark Liver Oils Market Insights and Forecast to 2026
MRC2-11QY09417 2020年11月25日 111Pages
当調査資料はサメ肝油のグローバル市場について調査・分析したレポートです。種類別（スクアレン、トリテルペノイド（C30H50））市場規模、用途別（食品産業、繊維産業、製薬産業、燃料、化粧品・パーソナルケア産業）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシ...

脂肪酸サプリメントの世界市場（～2026年）

Global Fatty Acid Supplements Market Insights and Forecast to 2026
MRC2-11QY05974 2020年11月20日 110Pages
当調査資料は脂肪酸サプリメントのグローバル市場について調査・分析したレポートです。種類別（オメガ3、オメガ6）市場規模、用途別（小売店、オンラインストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、...

タラ肝油の世界市場（～2026年）

Global Cod Liver Oil Market Insights and Forecast to 2026
MRC2-11QY00376 2020年11月20日 119Pages
当調査資料はタラ肝油のグローバル市場について調査・分析したレポートです。種類別（カプセル、経口液剤、粉末、その他）市場規模、用途別（医薬品、化粧品、動物飼料、食品・飲料、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、...

非アルコール性脂肪性肝疾患治療の世界市場（～2026年） Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…
非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …
遊離脂肪酸受容体4の世界市場（～2026年） Market Analysis and Insights: Global Free Fatty Acid Receptor 4 Market The global Free Fatty Acid Receptor 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Free Fatty Acid Receptor 4 Scope and Market Size Free Fatty A…
オメガ3多価不飽和脂肪酸の世界市場（～2026年） Omega−3 fatty acids are polyunsaturated fatty acids. Omega−3 fatty acids are important for normal metabolism. Global omega-3 polyunsaturated fatty acid market is growing at a modest rate due to significant consumption of omega-3 in dietary supplements and pharmaceuticals industries from across the g…
肝疾患治療の世界市場（～2026年） Liver diseases are of different types such as hepatitis, liver cancer, non-alcoholic fatty liver disease, and liver cirrhosis. Viral hepatitis is one of the major liver diseases affecting a large number of people across the globe. Market Analysis and Insights: Global Liver Disease Treatment Market T…